Danish industry pleads device cause:
This article was originally published in Clinica
Executive Summary
An organogram of Denmark's new Medicines Agency makes no mention of medical devices, despite the fact that device regulation will be the responsibility of the pharmacotherapeutic secretariat. The Danish Medical Device Association (DMDA) says it hopes the importance of devices will be upgraded in the new organisation (see Clinica No 746, p 2). On May 1st, the DMDA was due to meet Ib Bo Lumholtz, who took over as director of the Medicines Agency on March 1st, to discuss the allocation of resources to the device area.
You may also be interested in...
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.
Lilly Can Rest Easy As Tirzepatide Scores Phase III Sleep Apnea Win
Topline results from two studies in obstructive sleep apnea among obese adults showed efficacy crossing the 50% threshold that physicians have called clinically meaningful.